Evidence map›Paper›PMID 27447901›Full record

ReviewHormones & cancer2016

Prostate Cancer in African American Men: The Effect of Androgens and microRNAs on Epidermal Growth Factor Signaling.

Assumpta C Nwaneri, Lucien McBeth, Terry D Hinds

Open access · greenAbstract readReview
In one paragraph

Review in Hormones & cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Assumpta C NwaneriDepartment of Physiology & Pharmacology, Center for Hypertension and Personalized Medicine, University of Toledo College of Medicine, 3000 Arlington Avenue, Mailstop 1008, Toledo, OH, 43614, USA.
Lucien McBethDepartment of Physiology & Pharmacology, Center for Hypertension and Personalized Medicine, University of Toledo College of Medicine, 3000 Arlington Avenue, Mailstop 1008, Toledo, OH, 43614, USA.
Terry D HindsDepartment of Physiology & Pharmacology, Center for Hypertension and Personalized Medicine, University of Toledo College of Medicine, 3000 Arlington Avenue, Mailstop 1008, Toledo, OH, 43614, USA. Terry.Hinds@utoledo.edu.
University of Toledo · US

Funding

Antioxidant-PPARalpha interaction and hypertensionK01HL125445 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI HINDS, TERRY D · 2015 to 2019
$779k
NHLBI NIH HHS K01 HL125445NIMHD NIH HHS L32 MD009154
6 · The paper itself

Abstract

Prostate cancer (PC) is one of the leading causes of mortality amongst elderly men in the USA and is second only to lung cancer. African Americans (AA) are at an increased risk of developing PC and are more likely to die from the disease in comparison to Caucasian Americans (CA). Chromosomal alterations or genetic differences between AA and CA may account for the variances observed in PC progression. Importantly, mutations in the androgen receptor (AR) or the epidermal growth factor receptor (EGFR) may contribute to the disparity. Current studies are investigating the role of small nucleotide polymorphisms (SNPs) and microRNAs (miRNAs), which affect protein translation of the receptors by regulation of the 3' untranslated region (UTR), which may enhance the progression of PC. However, these genetic differences have not been fully explored in prostates between the two ethnic groups. This review will highlight the current studies on the EGFR signaling pathway as well as the involvement of SNPs and miRNAs and relate them to variances observed in PC of AA and CA men. With an understanding of these differences, specific preventive and therapeutic strategies may be developed to target personalized medicine for prostate carcinogenesis.

Indexed as

AndrogensBlack or African AmericanDisease ProgressionErbB ReceptorsGene Expression Regulation, NeoplasticGenetic Predisposition to DiseaseHumansMaleMicroRNAsPolymorphism, Single NucleotidePrecision MedicineProstatic NeoplasmsSignal TransductionWhite PeopleAndrogensEGFR protein, humanErbB ReceptorsMicroRNAs

Identifiers

PMID27447901
PMCPMC8817223
OpenAlexW2489472152

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.